The effect of heart rate control with beta-blocker in the acute phase of myocardial infarction on hemodynamic and functional outcomes.
Not Applicable
- Conditions
- Acute Myocardial Infarction
- Registration Number
- JPRN-UMIN000004782
- Lead Sponsor
- Sakurabashi Watanabe Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1)cardiogenic Shock (2)severe deterioration of liver function (3)history of beta-blocker or amiodarone treatment (4)history of side effects or contraindication of beta-blocker (5)hypersensitivity to trial medicine (6)doctor's decision not to register to this regimen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) estimated infarct size (2) left ventricular function (left ventricular ejection fraction ) (3)incidence of arrhythmia (especially atrial fibrillation , ventricular tachycardia and ventricular fibrillation).
- Secondary Outcome Measures
Name Time Method (1) survival rate (2) reperfusion injury (ie, malignant ventricular arrhythmia , re-elevation of ST-segment and worsening of chest pain after reperfusion) (3)cardiovascular events (ie, cardiac death, nonfatal infarction, re-hospitalization because of cardiac disease, revascularization)